Search
Now showing items 11-16 of 16
VS411 Reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics
(PLoS One, 2012)
Background: A new class of antiretrovirals, AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs), has been proposed as a disease-modifying therapy to both reduce Human Immunodeficiency Virus Type 1 (HIV-1) RNA levels ...
Impaired T-cell proliferation among HAARTtreated adults with suboptimal CD4 recovery in an African cohort
(BMC Immunology, 2013)
Background: Most HIV-infected subjects exhibit a progressive rise in CD4 T-cell counts after initiation of highly active antiretroviral therapy (HAART). However, a subset of individuals exhibit very poor CD4 T-cell recovery ...
A consortium approach to competency‑based undergraduate medical education in Uganda: Process, opportunities and challenges.
(Medknow Publications, 2014)
ABSTRACT
Background: Uganda, like the rest of Africa, is faced with serious health challenges including human immunodeficiency virus infection/
acquired immunodeficiency syndrome (HIV/AIDS), other infectious diseases and ...
Factors affecting utilization of post-exposure prophylaxis of HIV/AIDS among health care personnel.
(2014-10-03)
This research was aimed at understanding the factors that influence utilization of Post Exposure Prophylaxis (PEP) of HIV among Health Care Personnel (HCP) after occupational exposure. It was done because in Uganda, more ...
The clinical utility of cystatin c in assessing renal function among HIV/AIDS patients on ART at Mildmay Uganda
(Makerere University, 2016-04)
Background: The risk of death form renal disease among HIV positive individuals can be reduced by early detection and appropriate monitoring. Measurement of glomerular filtration rates is the gold standard assessing renal ...
Hearing loss associated with Kanamycin in patients treated for multi-drug-resistant Tuberculosis at Mulago Hospital
(Makerere University, 2016)
Introduction
Aminoglycosides form part of the second-line drugs used in treatment of Multi-drug resistant tuberculosis. Cochleotoxicity is one of the side effects of aminoglycosides. It usually presents as permanent, ...